Anukriti Sharma1, Bharathi Laxman2, Edward T Naureckas2, D Kyle Hogarth2, Anne I Sperling2, Julian Solway2, Carole Ober3, Jack A Gilbert1, Steven R White4. 1. Department of Surgery, University of Chicago, Chicago, Ill; Biosciences Division (BIO), Argonne National Laboratory, Argonne, Ill; Department of Pediatrics and Scripps Institution of Oceanography, University of California San Diego, La Jolla, Calif. 2. Section of Pulmonary and Critical Care Medicine, Department of Medicine, University of Chicago, Chicago, Ill. 3. Department of Human Genetics, University of Chicago, Chicago, Ill. 4. Section of Pulmonary and Critical Care Medicine, Department of Medicine, University of Chicago, Chicago, Ill. Electronic address: swhite@bsd.uchicago.edu.
Abstract
BACKGROUND: The relationship between asthma, atopy, and underlying type 2 (T2) airway inflammation is complex. Although the bacterial airway microbiota is known to differ in asthmatic patients, the fungal and bacterial markers that discriminate T2-high (eosinophilic) and T2-low (neutrophilic/mixed-inflammation) asthma and atopy are still incompletely identified. OBJECTIVES: The aim of this study was to demonstrate the fungal microbiota structure of airways in asthmatic patients associated with T2 inflammation, atopy, and key clinical parameters. METHODS: We collected endobronchial brush (EB) and bronchoalveolar lavage (BAL) samples from 39 asthmatic patients and 19 healthy subjects followed by 16S gene and internal transcribed spacer-based microbiota sequencing. The microbial sequences were classified into exact sequence variants. The T2 phenotype was defined by using a blood eosinophil count with a threshold of 300 cells/μL. RESULTS: Fungal diversity was significantly lower in EB samples from patients with T2-high compared with T2-low inflammation; key fungal genera enriched in patients with T2-high inflammation included Trichoderma species, whereas Penicillium species was enriched in patients with atopy. In BAL fluid samples the dominant genera were Cladosporium, Fusarium, Aspergillus, and Alternaria. Using generalized linear models, we identified significant associations between specific fungal exact sequence variants and FEV1, fraction of exhaled nitric oxide values, BAL fluid cell counts, and corticosteroid use. Investigation of interkingdom (bacterial-fungal) co-occurrence patterns revealed different topologies between asthmatic patients and healthy control subjects. Random forest models with fungal classifiers predicted asthma status with 75% accuracy for BAL fluid samples and 80% accuracy for EB samples. CONCLUSIONS: We demonstrate clear differences in bacterial and fungal microbiota in asthma-associated phenotypes. Our study provides additional support for considering microbial signatures in delineating asthma phenotypes.
BACKGROUND: The relationship between asthma, atopy, and underlying type 2 (T2) airway inflammation is complex. Although the bacterial airway microbiota is known to differ in asthmatic patients, the fungal and bacterial markers that discriminate T2-high (eosinophilic) and T2-low (neutrophilic/mixed-inflammation) asthma and atopy are still incompletely identified. OBJECTIVES: The aim of this study was to demonstrate the fungal microbiota structure of airways in asthmatic patients associated with T2 inflammation, atopy, and key clinical parameters. METHODS: We collected endobronchial brush (EB) and bronchoalveolar lavage (BAL) samples from 39 asthmatic patients and 19 healthy subjects followed by 16S gene and internal transcribed spacer-based microbiota sequencing. The microbial sequences were classified into exact sequence variants. The T2 phenotype was defined by using a blood eosinophil count with a threshold of 300 cells/μL. RESULTS: Fungal diversity was significantly lower in EB samples from patients with T2-high compared with T2-low inflammation; key fungal genera enriched in patients with T2-high inflammation included Trichoderma species, whereas Penicillium species was enriched in patients with atopy. In BAL fluid samples the dominant genera were Cladosporium, Fusarium, Aspergillus, and Alternaria. Using generalized linear models, we identified significant associations between specific fungal exact sequence variants and FEV1, fraction of exhaled nitric oxide values, BAL fluid cell counts, and corticosteroid use. Investigation of interkingdom (bacterial-fungal) co-occurrence patterns revealed different topologies between asthmatic patients and healthy control subjects. Random forest models with fungal classifiers predicted asthma status with 75% accuracy for BAL fluid samples and 80% accuracy for EB samples. CONCLUSIONS: We demonstrate clear differences in bacterial and fungal microbiota in asthma-associated phenotypes. Our study provides additional support for considering microbial signatures in delineating asthma phenotypes.
Authors: Vladimir Svetnik; Andy Liaw; Christopher Tong; J Christopher Culberson; Robert P Sheridan; Bradley P Feuston Journal: J Chem Inf Comput Sci Date: 2003 Nov-Dec
Authors: Bart G J Dekkers; Anita I R Spanjer; Robert D van der Schuyt; Willem Jan Kuik; Johan Zaagsma; Herman Meurs Journal: J Pharmacol Exp Ther Date: 2013-04-16 Impact factor: 4.030
Authors: Amnon Amir; Daniel McDonald; Jose A Navas-Molina; Evguenia Kopylova; James T Morton; Zhenjiang Zech Xu; Eric P Kightley; Luke R Thompson; Embriette R Hyde; Antonio Gonzalez; Rob Knight Journal: mSystems Date: 2017-03-07 Impact factor: 6.496
Authors: Luke R Thompson; Jon G Sanders; Daniel McDonald; Amnon Amir; Joshua Ladau; Kenneth J Locey; Robert J Prill; Anupriya Tripathi; Sean M Gibbons; Gail Ackermann; Jose A Navas-Molina; Stefan Janssen; Evguenia Kopylova; Yoshiki Vázquez-Baeza; Antonio González; James T Morton; Siavash Mirarab; Zhenjiang Zech Xu; Lingjing Jiang; Mohamed F Haroon; Jad Kanbar; Qiyun Zhu; Se Jin Song; Tomasz Kosciolek; Nicholas A Bokulich; Joshua Lefler; Colin J Brislawn; Gregory Humphrey; Sarah M Owens; Jarrad Hampton-Marcell; Donna Berg-Lyons; Valerie McKenzie; Noah Fierer; Jed A Fuhrman; Aaron Clauset; Rick L Stevens; Ashley Shade; Katherine S Pollard; Kelly D Goodwin; Janet K Jansson; Jack A Gilbert; Rob Knight Journal: Nature Date: 2017-11-01 Impact factor: 49.962
Authors: Daniel McDonald; Jose C Clemente; Justin Kuczynski; Jai Ram Rideout; Jesse Stombaugh; Doug Wendel; Andreas Wilke; Susan Huse; John Hufnagle; Folker Meyer; Rob Knight; J Gregory Caporaso Journal: Gigascience Date: 2012-07-12 Impact factor: 6.524
Authors: Sharon M Carney; Jose C Clemente; Michael J Cox; Robert P Dickson; Yvonne J Huang; Georgios D Kitsios; Kirsten M Kloepfer; Janice M Leung; Tricia D LeVan; Philip L Molyneaux; Bethany B Moore; David N O'Dwyer; Leopoldo N Segal; Stavros Garantziotis Journal: Am J Respir Cell Mol Biol Date: 2020-03 Impact factor: 6.914
Authors: Juliana Durack; Laura S Christian; Snehal Nariya; Jeanmarie Gonzalez; Nirav R Bhakta; K Mark Ansel; Avraham Beigelman; Mario Castro; Anne-Marie Dyer; Elliot Israel; Monica Kraft; Richard J Martin; David T Mauger; Stephen P Peters; Sharon R Rosenberg; Christine A Sorkness; Michael E Wechsler; Sally E Wenzel; Steven R White; Susan V Lynch; Homer A Boushey; Yvonne J Huang Journal: J Allergy Clin Immunol Date: 2020-04-13 Impact factor: 10.793
Authors: Matthew S Godwin; MaryJane Jones; Jonathan P Blackburn; Zhihong Yu; Sadis Matalon; Annette T Hastie; Deborah A Meyers; Chad Steele Journal: Am J Physiol Lung Cell Mol Physiol Date: 2020-12-16 Impact factor: 5.464
Authors: Matthew A Tyler; Kent Lam; Michael J Marino; William C Yao; Isaac Schmale; Martin J Citardi; Amber U Luong Journal: Int Forum Allergy Rhinol Date: 2021-06-02 Impact factor: 3.858